KOD

Kodiak Sciences Inc.

Price

$40.07

return (12m)

322.68%

p/e

-10.65

p/bv

42.19

DIVIDEND YIELD

0.00%

KOD price

Kodiak Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KOD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.16%

3 months

7.11%

1 year

322.68%

2 years

1,412.08%

5 years

118.94%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals KOD

Valuation

P/E

-10.65

Sector -4.38

Industry -4.38

P/BV

42.19

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-40.42

Sector -263.09

Industry -263.09

EV/EBIT

-36.68

Sector -702.90

Industry -702.90

P/EBITDA

-11.91

Sector -4.39

Industry -4.39

P/EBIT

-10.65

Sector -4.73

Industry -4.73

P/Total Assets

10.04

Sector 1.49

Industry 1.49

P/Net Current Assets

-40.05

Sector -11.70

Industry -11.70

P/Working Capital

32.80

Sector -3.19

Industry -3.19

EPS

-3.84

Sector -2.14

Industry -2.14

BVPS

0.97

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-396.07%

Sector -65.14%

Industry -65.14%

ROA

-94.23%

Sector -65.53%

Industry -65.53%

ROIC

-192.57%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.49

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.08

Sector -6.07

Industry -6.07

Net Debt / EBIT

1.88

Sector -8.26

Industry -8.26

Net Debt / Equity

-2.06

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.24

Sector 0.41

Industry 0.41

Liabilities/Assets

0.76

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-1.95%

Sector -

Industry -

Fundamentals KOD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
KOD Kodiak Sciences Inc.	$40.07	256.18%	0.00%	-10.65	42.19	-396.07%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KOD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Kodiak Sciences

Kodiak Sciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

17 years

Founded: 2009

2018

Time since IPO - 8 years

72

Employees

Kodiak Sciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.58 billion, with shareholders equity totaling $61.10 million.

The company employs approximately 72 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kodiak Sciences Inc. reported $- in revenue, generating net income of $-242.00 million.

Key financial metrics include a P/E ratio of -10.65, a price-to-book (P/B) ratio of 42.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KOD.

Market cap

$2.58 billion

Net worth

$61.10 million

$61,100,000.00

Assets

$256.81 million

$256,810,000.00

Total Shares Outstanding

63.00 million

63,000,000

Average Daily Trading Volume

$726.17 Thousand

$726,165.84

Sector

Health Care

Industry

Biotechnology

KOD

KOD revenue and profits

Financial Results KOD

DRAG THE FRAME TO SEE MORE DATA

KOD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Kodiak Sciences (KOD) today?

A cotação de Kodiak Sciences (KOD) hoje está em US$ 40.07, com uma variação de 322.68% em relação ao último ano. A cotação de Kodiak Sciences (KOD) iniciou o ano negociando na casa dos US$ 27.96 e hoje está em US$ 40.07. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Kodiak Sciences (KOD) e dados de ações do Ibovespa e mercados internacionais.

Quando Kodiak Sciences (KOD) paga dividendos?

Kodiak Sciences (KOD) não distribuiu dividendos no último ano.

Is Kodiak Sciences (KOD) a good investment?

Atualmente, Kodiak Sciences (KOD) está cotada a US$ 40.07, com um P/L de -10.65, representando um desvio de -439% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 322.68 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 322.68%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kodiak Sciences (KOD) stock?

Investir em ações de Kodiak Sciences (KOD) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Kodiak Sciences (KOD) yield today?

A rentabilidade de Kodiak Sciences (KOD) foi de -7.16% no último mês, 322.68% no último ano e 118.94% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Kodiak Sciences (KOD) hoje, o investimento total seria de US$ 4,007.00, com base na cotação atual de US$ 40.07.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 16,936.79
Em 5 anos: US$ 8,772.93
Em 10 anos: US$ 4,007.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KOD

Kodiak Sciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KOD

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING KOD WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Kodiak Sciences

Kodiak Sciences Inc.

United States

17 years

2018

72

PROFIT X PRICE KOD

Financial Results KOD

KOD cash flow

Asset, Revenue and Profit Growth - KOD

KOD balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions